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During the period 1981 to 1992, 4,473 fecal specimens collected from children hospitalized with acute
gastroenteritis at the Royal Children’s Hospital, Melbourne, Australia, were examined by electron microscopy.
A monoclonal antibody enzyme immunoassay for enteric adenovirus (EAd) types 40 (Ad40) and 41 (Ad41) was
used when adenoviruses were visualized. Fecal samples were positive for adenovirus by both electron
microscopy and enzyme immunoassay in 138 patients (3.1%). Ad40 was identified in 19 children (14%), and
Ad41 was identified in 119 children (86%). These EAd were identified during each of the 12 years surveyed. EAd
were present year-round, but the annual number of hospitalizations was not constant. Yearly prevalence varied
from 0.7% (1981) to 6.5% (1985). This was associated with monthly fluctuations in Ad41 activity, with overall
peak monthly prevalence in May (late autumn). By contrast, Ad40 numbers remained low and constant
year-round. The frequency of Ad41 relative to Ad40 increased from 25% in 1981 to exceed 75% after 1983.
Children admitted with EAd infection were more likely to have diarrhea for more than 5 days (P < 0.001) but
less likely to be febrile or dehydrated (P < 0.05) than children with rotavirus infection. EAd are responsible
for enteric symptoms of only a fraction of hospitalized children with infectious diarrhea but result in a
more-protracted illness than rotavirus. Their relationship to persistent diarrhea requires further investigation.
Many of the 47 human adenovirus serotypes currently
recognized can be shed in stools, often for prolonged periods,
without being associated with diarrhea (31). There is strong
epidemiologic and serologic evidence that infection with ade-
novirus 40 (Ad40) and adenovirus 41 (Ad41) can result in
severe acute diarrhea in young children (31). These two
serotypes form the F subgroup of the adenovirus genus, exhibit
cross-reactivity in viral neutralization assays, and are colloqui-
ally referred to as enteric adenoviruses (EAd). The members
of this subgroup are difficult to grow in cell culture, and this has
delayed the development of specific diagnostic tests.
Following the introduction of monoclonal-antibody-based
enzyme immunoabsorbent assays (EIA), epidemiologic studies
have been conducted on their role as etiologic agents of severe
acute infectious diarrhea (12). These studies have shown that
Ad40 and Ad41 have a worldwide distribution and are of
comparable prevalence in developed and developing countries
and in urban and rural communities (3, 4, 7, 13, 26). EAd have
also been implicated in nosocomial infections and day care
center outbreaks (15, 29).
Etiologic surveys of fecal specimens collected over 2 to 9
years from children admitted to hospital with gastroenteritis
show nonseasonal patterns of infection by EAd in different
communities (3, 4, 22, 33). Although early surveys observed
approximately equal prevalence of Ad40 and Ad41, recent
reports indicate that these serotypes may occur within commu-
nities at different rates. Ad41 may undergo antigenic drift,
raising the possibility of repeated community outbreaks due to
this serotype (6, 22). Even though EAd and rotaviruses both
produce as symptoms fever, vomiting, and watery diarrhea,
there are conflicting reports as to whether EAd infection
results in a milder but more prolonged illness than rotavirus (7,
13). The aims of this retrospective study of acute infective
diarrhea in children admitted to a large pediatric teaching
hospital were (i) to determine the rate of EAd gastroenteritis
in children admitted during a prolonged period (12 years), (ii)
to describe the annual and seasonal distribution of Ad40 and
Ad41 gastroenteritis, and (iii) to compare the clinical features
of infections due to Ad40 and those due to Ad41 and the
clinical features of EAd and rotavirus gastroenteritis in pa-
tients hospitalized during the study period.
MATERIALS AND METHODS
Study population and sample collection. All children admitted to the Royal
Children’s Hospital (RCH) in Melbourne, Australia, with acute diarrhea are
nursed in the infectious diseases ward. During a 12-year period, from 1981 to
1992 inclusive, stool specimens were collected from 4,473 patients within 48 h of
admission. Feces were prepared as 10% homogenates in phosphate-buffered
saline (PBS; pH 7.4), clarified by low-speed centrifugation at 600 3 g for 10 min,
and concentrated approximately 10-fold by polyacrylamide hydrogel (Lyphogel;
Gelman Sciences, Inc.) before negative staining with ammonium molybdate (pH
7.0) (32). Grids were stored for 1 to 2 weeks before examination by electron
microscopy (EM). Adenovirus particles were identified by their characteristic
morphology. Stool specimens containing adenovirus particles were stored at
2708C until further tested by EIA.
EIA detection of adenovirus group antigen, Ad40, and Ad41. Mouse ascites
fluid containing antiadenovirus monoclonal antibodies MA 1-3 (group antigen
specific), MA 5-8 (specific for Ad40), and MA 5-15 (specific for Ad41) were used
in a double-sandwich EIA modified after Jarecki-Khan et al. (13). The mono-
clonal antibodies had been donated by J. C. de Jong of Rijksinstituut Voor
Volksgezondheid en Milieuhygiene, Bilthoven, The Netherlands.
Hyperimmune rabbit antihexon antiserum was produced in rabbits (27) and
used to coat microtiter plates (Nunc-Maxisorp, Roskilde, Denmark) at a dilution
of 1/2,000 in carbonate buffer (pH 9.6). One hundred microliters was added to
each well and bound overnight at 48C. Test samples comprising 100 ml of 10%
(wt/vol) fecal homogenates in PBS (pH 7.2) were added to each well and
incubated at 378C for 1 h. One hundred microliters of mouse monoclonal
antibody diluted 1/1,000 in PBS (pH 7.1) containing 20% fetal calf serum and 2%
Tween 20 (PBST) was added and incubated at 378C for a further 1 h. Reactions
were detected with sheep anti-mouse immunoglobulin G–horseradish peroxidase
conjugate (Silenus, Melbourne, Australia), diluted 1/200 in PBST, followed by
substrate containing o-phenylenediamine hydrochloride (Sigma, St. Louis, Mo.).
This reaction proceeded at room temperature in the dark for 15 min before being
stopped by addition of 25 ml of 4 N HCl to all wells. The optical density at 490
nm (OD490) for each well was read with a Titertek EIA reader. Each fecal
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specimen was tested in triplicate against each of the three monoclonal detector
antibodies (i.e., nine tests per specimen). After each step, plates were washed
four times in PBS containing 0.1% Tween 20. The sensitivity and specificity of the
EIA were monitored by the addition of prototype strains Ad40 (Dugan) and
Ad41 (Tak) and of pooled nonenteric adenoviruses and a known negative sample
to each plate. Samples were considered to contain either Ad40 or Ad41 if the
OD490 for the respective wells was at least twice that of the negative control well
and greater than 0.2 OD units. Samples which reacted only with MA 1-3 were
considered to contain only nonenteric adenoviruses.
Clinical data and assessment.Hospital records of children with EAd infection
were reviewed by K. Grimwood while blinded to the EIA results (Ad40 and
Ad41). Clinical observations had been recorded by resident medical officers and
nursing staff during the period of each child’s admission to hospital. The
preadmission clinical histories were obtained from parents or guardians. Resi-
dent medical officers determined dehydration by clinical signs. Serum electro-
lytes and pH were measured at the discretion of the admitting doctor.
A severity score devised by Riepenhoff-Talty et al. (20) and described in Table
1 was assigned to each patient. The maximum number of stools or vomits
reported prior to admission or in hospital was recorded. Where documentation
was not precise (29 of 138 patients), a score of 1 was assigned for the category
infrequent or occasional, a score of 2 was assigned for frequent, and a score of
3 was assigned for profuse or persistent (2). Duration of diarrhea and vomiting
was counted from the symptom onset until the last vomit or fluid stool passed
during recovery. The maximum temperature read prior to or during admission
was recorded.
Differences in clinical data and severity scores between children infected with
Ad40 (11) and those infected with Ad41 (77) were compared in a total of 88
children. All had community-acquired EAd gastroenteritis and no concurrent
enteric infection or underlying illness. Additional comparisons were made
between 62 of these patients with EAd infection, who fell into the same age range
of 6 to 30 months, and 108 previously reported rotavirus-infected children (2).
These latter subjects were between 6 and 30 months of age, were admitted to the
RCH infectious diseases ward during the same study period, and had undergone
an identical chart review.
Statistics. Minitab computer software (16) provided descriptive statistics and
comparisons of ordinal variables by the nonpaired t test or the Mann-Whitney
test. Comparisons of nominal variables by the x2 test or Fisher’s exact test, risk
ratios, and 95th-percentile confidence intervals were performed with the Epi Info
statistics program (8). Children who scored $2 for each individual sign or
symptom for the clinical score (i.e., moderate or severe) were compared between
EAd serotypes and with rotavirus.
RESULTS
During the 12-year stool collection period, 4,473 children
were admitted to the infectious diseases ward at RCH with
acute gastroenteritis. Adenovirus particles, observed by EM
and later confirmed as positive for the hexon group antigen by
EIA, were present in the stools of 154 children (3.4%). Of
these 154 adenovirus-positive specimens, 138 (3.1%) belonged
to Ad40 or Ad41 serotypes. Rotaviruses were detected in the
stools of 1,553 children (34.7%) admitted to hospital with
acute gastroenteritis during the same period.
The annual distribution of EAd gastroenteritis admissions to
the RCH between 1981 and 1992 is shown in Fig. 1. Nineteen
children had Ad40 (14%), and 119 (86%) had Ad41, in their
stools. During the study period, the percentage of Ad41
increased from 25% in 1981 to 93% in 1984, after which it
remained greater than 75% each year and was 100% in 1989
and 1992. The number of EAd gastroenteritis admissions was
not constant over the 12 years. This was principally due to
fluctuations in Ad41 prevalence dating back to 1983.
The annual rates of children hospitalized because of EAd
gastroenteritis, as a proportion of the total number of children
admitted to the infectious diarrhea ward, is shown in Fig. 2.
There was a significant variation in rates of EAd gastroenteritis
admissions over time (P , 0.001), and when adjusted for
rotavirus admissions this remained highly statistically signifi-
cant (P , 0.001). Annual rates fluctuated from 0.7% in 1981,
when Ad40 was dominant, to peaks of 6.5 and 6.3% in 1985
and 1992, respectively, following the increased prevalence of
Ad41. The monthly distribution of EAd gastroenteritis admis-
FIG. 1. Annual numbers of children with EAd gastroenteritis admitted to the RCH, 1981 to 1992.
TABLE 1. Scoring for severity of acute gastroenteritis
Symptom




Maximum no. of stools/day ,5 5–8 .8
Duration (days) ,5 5–7 .7
Vomiting
Maximum no. of vomits/day ,4 4–6 .6
Duration (days) ,3 3–5 .5
Dehydration (% body weight
loss)
,5 5–9 .9
Fever (8C) ,38.5 38.5–38.9 .38.9
Acidosis 7.34–7.30 ,7.30
Electrolyte abnormality Present
a After Rieppenhoff-Talty et al. (20).










sions is outlined in Fig. 3. Although there was no association
between Ad40 or Ad41 and season, the total number of EAd
admissions was not constant throughout the year, and a peak in
May was observed during 6 of the 12 years of the study (P 5
0.002). This observation was also true for the monthly rates of
EAd infection calculated as a proportion of total gastroenter-
itis admissions (P 5 0.002). Although constant for 10 months
of the year with values of between 2 and 4%, rates fell below
2% in July and rose to 7.2% in May to account for much of the
variance.
The clinical features of the 138 children with Ad40 and Ad41
gastroenteritis are shown in Table 2. There were no significant
differences regarding composition or clinical symptoms be-
tween the two groups of children. The sex ratio was 1.2:1 in
favor of males, and 90% of patients were younger than 2 years.
During the first year of life there were approximately equal
numbers of children younger or older than 6 months (25 versus
29, respectively). The principal symptoms were vomiting (89%)
and diarrhea (100%). The children had been unwell with
vomiting or diarrhea for a mean period of 4.8 days prior to
hospitalization. The diarrhea was prolonged and ranged from
1 to 60 days with a mean and median duration of 9 and 7 days,
respectively. Although 23% of patients had mucous stools,
frank blood was not reported. High fevers or rashes were
uncommon, but respiratory symptoms such as cough or coryza
were present in 32% of cases. The illness was complicated by
dehydration in 33% of the children, and lactose intolerance
was detected in 12% of the children. Overall, 24 patients
(17%) had mixed infections. Enteric copathogens were iden-
tified in 14 patients (10%). Exclusion of these 14 patients from
analysis did not alter our results. This may have been due to
small patient numbers and to equal division between those
with a brief rotavirus illness (n 5 7) and those experiencing
prolonged symptoms associated with Salmonella (n 5 4),
Campylobacter (n5 3), and Cryptosporidium (n5 1) infections.
Thirty-eight patients (28%) had other illnesses, such as bron-
FIG. 2. Annual rate of children with EAd gastroenteritis per total number of
gastroenteritis admissions to the RCH, 1981 to 1992.
FIG. 3. Monthly numbers of children with EAd gastroenteritis admitted to the RCH, 1981 to 1992.
TABLE 2. EAd gastroenteritis at the RCH, 1981 to 1992
Characteristic
Value for virus of
indicated serotype
Ad40 Ad41
No. of patientsa 19 119
Sex (no. of males/no. of females) 7/12 69/50
Age (months)b 7.0 (1–41) 9.0 (1–61)
Diarrhea
Maximum no. of stools/dayb 5.0 (2–20) 7.0 (2–25)
Days of diarrheab 7.0 (2–25) 7.0 (1–60)
Mucus in stools (%) 11 25
Vomitsb
Maximum no. of vomits/day 5.0 (2–10) 4.0 (0–20)
Days of vomiting 4.0 (1–9) 3.0 (0–15)
No. of patients (%) with:
Respiratory symptoms 7 (37) 36 (30)
$5% dehydration 5 (26) 40 (34)
Sugar intolerance 1 (5) 15 (13)
Copathogens 3 (16) 21 (18)
Concomitant disease 6 (32) 32 (27)
No. of days in hospitalb 4.0 (2–25) 4.0 (1–34)
a P , 0.001 (P . 0.05 for all other comparisons).
b Results are expressed as median (range).










chiolitis (n 5 5) or chronic cardiorespiratory disorders (n 5
16), which influenced their admission criteria and length of
hospital stay.
A comparison of disease severity between EAd and rotavirus
gastroenteritis is outlined in Table 3. Although no differences
in clinical scores were observed, patients hospitalized with
EAd infection were less likely to have high fever or dehydra-
tion (P , 0.05) but their symptoms of vomiting and diarrhea
were more protracted than those observed for children with
rotavirus gastroenteritis (P , 0.005). When these comparisons
were made between 11 children with Ad40 and 77 children
with Ad41 infection, no differences in either clinical scores or
severity of symptoms were detected.
DISCUSSION
This study has shown that over a 12-year period, 3.1% of
children admitted with gastroenteritis to a major Australian
pediatric hospital had EAd detected in their feces. EAd were
identified in a proportion of children in each of the 12 years.
Rates of admission each year varied from 0.7% (1981) to 6.5%
(1985) of children with gastroenteritis. This is in general
agreement with studies from other developed countries, where
the frequency of EAd infection in hospitalized populations has
been reported to be 1.1 to 7.9% (9, 22, 31, 34). EAd are also
common causes of gastroenteritis in developing countries. The
rates of infection in children from these countries vary widely.
Studies from Thailand and Bangladesh have reported EAd
gastroenteritis in less than 3% of outpatients, compared with
26% in children from the highlands of Papua New Guinea and
31% in hospitalized rural Guatemalan children (7, 11, 13, 25).
This wide variation in detection rates amongst developing
countries remains unexplained, but studies have been cross-
sectional and the results may reflect fluctuations of EAd
infection in these regions. Seroprevalence studies from many
countries have shown that almost all children experience an
EAd infection by 4 years of age (14, 23).
This study did not attempt to define hospital-acquired
infection. Other hospital-based series indicate that nosocomi-
ally acquired EAd infections form a major proportion of cases
(15, 31). Rates obtained from outpatient settings or family
studies have shown a similar range of 2 to 5.4% for EAd
gastroenteritis (17, 21). An earlier survey from Melbourne
reported that 8.9% of children who presented to a primary
care facility and 7.4% of children admitted to hospital with
acute diarrhea had EAd identified from fecal specimens (19).
However, this study was conducted during a 7-month period
and the diagnosis of an EAd infection was made by the
visualization of adenovirus particles in feces by EM and their
failure to grow, or to be passaged, in routine cell culture used
for viral diagnosis. The short period of observation and the use
of less-specific diagnostic techniques could have led to an
overestimate of EAd infection. Our results indicate that ap-
proximately 90% of adenoviruses visualized by EM can be
identified as EAd by use of monoclonal antibodies specific for
Ad40 and Ad41 in an EIA system.
An unexpected observation was the overall predominance of
Ad41 as the agent of EAd gastroenteritis. The literature has
generally reported equal frequencies for Ad40 and Ad41 (10,
13). However, recent longitudinal studies from England (3,
33), Canada (6), Japan (22), and The Netherlands (9) have
recorded substantial annual decreases in numbers of Ad40-
positive fecal specimens. The shifts in EAd serotype were first
detected during the mid-1980s, and only one study reported a
subsequent increase in Ad40 isolation rates (3). Our results
show fairly constant, but minimal, numbers of Ad40 infections
for 10 of the 12 years surveyed.
An important finding was the significant fluctuations in
annual rates for EAd gastroenteritis that were related to
fluctuations in Ad41 activity. Annual prevalence of EAd in
relation to all other gastroenteritis admissions (Fig. 2) suggests
that the two peaks of EAd infections (1985 and 1992) may
represent two sustained epidemics perhaps caused by antigenic
changes in Ad41. It is possible that epidemics of EAd gastro-
enteritis elsewhere have gone undetected in other longitudinal
studies of short duration. Determination of DNA restriction
endonuclease digestion patterns provides evidence that EAd is
highly heterogeneous (1, 31). At least six different genome
types of Ad40 were identified in fecal specimens from South
Africa, Canada, and Europe. Canadian and European strains
of Ad41 were identical, but four different genomic types were
identified among South African strains (31). Difficulties expe-
rienced in adapting EAd to growth in cell culture have
inhibited epidemiologic studies of genomic variation among
field strains of subgenus F adenoviruses. The recent promising
development of specific monoclonal antibodies directed
against antigenic determinants in the hexon region has been
tempered by this genomic variation (9, 18). Changes in
genomic restriction patterns and in monoclonal subtypes of
Ad41 have been described as coinciding with increased fecal
isolation rates of this serotype in children admitted to hospital
and with outbreaks in day care centers but not with an overall
increase in the rate of EAd disease within the community (9,
28). Serial alterations of Ad41 antigenic determinants resem-
ble the antigenic drift of the influenza virus (30). As a result, it
has been suggested that each alteration in Ad41 antigens may
be followed by an increase in EAd gastroenteritis as the
proportion of susceptible individuals within the community is
increased. Until now, no study has shown significant fluctua-
tions in EAd rates suggestive of such a relationship. Because
vaccine development needs to consider changes within neutral-
ization epitopes, additional studies examining the genomic and
antigenic variations of the EAd serotypes are required.
Our results confirm that EAd infection occurs year-round
(9) and indicate that EAd infections were particularly preva-
lent during the month of May, which is late autumn in the
Southern Hemisphere. Earlier studies have failed to detect
regular seasonal variations, although a recent study from
TABLE 3. Severity of clinical symptoms associated with infection
by EAd or rotaviruses in hospitalized children aged 6 to 30 months
Characteristic
Value with
indicated virus Risk ratioa P
EAd Rotavirus
No. of patients 62 108
Age (months)b 12.6 (5.7) 14.0 (5.6) 0.06
Sex (no. of males/no.
of females)
37/25 67/41 0.76
Scoreb 10.8 (2.9) 10.3 (3.1) 0.28
% of patients with
indicated symp-
tom(s)
$5 stools/day 79 76 1.0 (0.9,1.2) 0.64
$5 days of diarrhea 81 32 2.5 (1.9,3.4) ,0.001
$4 vomits/day 63 71 0.9 (0.7,1.1) 0.26
$3 days of vomiting 63 39 1.6 (1.2,2.2) 0.004
$5% dehydration 30 46 0.6 (0.4,1.0) 0.03
Temp $38.58C 6 42 0.15 (0.06,0.33) ,0.001
a The 95th percentile confidence interval is shown in parentheses.
bMean (standard deviation).










Bangladesh described a seasonal increase in EAd infections
during the dry winter period (13).
Admission to hospital preselects children with severe dis-
ease, so it was no surprise that there were few differences in
severity scores between patients with EAd infection and those
with rotavirus gastroenteritis. However, there were significant
differences in clinical characteristics between the two groups.
Children admitted to hospital with EAd were more likely to
have been unwell for several days with symptoms of vomiting
and diarrhea but less likely to have been highly febrile or
dehydrated. By contrast, young children with rotavirus infec-
tion were hospitalized with an acute history of fever, vomiting,
diarrhea, and dehydration. Our results support the contention
that patients suffering from EAd infection are likely to have a
protracted illness (31). Persistent gastrointestinal symptoms
may increase the risk of malnutrition in children from devel-
oping countries. Why children with an EAd infection should
have a longer illness is unclear. Neither an increased rate of
secondary lactose intolerance nor prolonged excretion of EAd
in the stools has been reported in children with EAd gastro-
enteritis (29). The children suffering from EAd tended to be
younger than those of the rotavirus comparison group, but
unlike some previous researchers (4, 9) we did not find a
preponderance in the first 6 months of life. However, even
when the analysis was repeated and included children younger
than 6 months with EAd, such that the difference in age groups
with rotavirus became highly significant (9.6 versus 14.0
months, respectively; P , 0.001), disease characteristics and
risk ratios remained unchanged. Thus, age difference does not
adequately explain the different clinical courses for both
viruses.
No differences in disease severity between young patients
admitted to hospital with Ad40 gastroenteritis and those with
Ad41 gastroenteritis were detected. As this was a hospital-
based study, it is possible that overrepresentation of Ad41 in
our sample population reflects severe disease caused by this
particular serotype. However, no such sample bias was ob-
served in day care centers, where outbreaks followed increased
Ad41 activity (28). The small numbers of children with an
Ad40 infection greatly reduced the power of the study to detect
even large differences between the two patient groups. Other
studies with small numbers and multiple subgroup analyses
have given conflicting results as to which serotype gives
more-severe symptoms (24, 31). A community-based study
with greater numbers of Ad40-infected subjects is required to
answer this question.
It is possible that we underestimated the true number of
EAd infections. Our approach to diagnosis, screening of fecal
samples by EM and confirmation by EIA, may be less sensitive
than use of a monoclonal-based EIA for initial diagnosis. All
samples containing adenovirus particles identified by EM
reacted in the EIA system. However, 10% reacted solely with
the group antigen-specific monoclonal antibody and were
likely to be cultivable adenoviruses of other serotypes. This is
consistent with observations made by others (5). It has been
shown that EM detects $106 particles per ml and that speci-
mens containing adenoviruses below the detection threshold
for EM would be recorded as negative.
Although less than 5% of Melbourne children hospitalized
with acute gastroenteritis had EAd present in their feces, this
pathogen was the second-most-common enteric virus detected
and was comparable to Salmonella and Campylobacter species
as a cause of infectious diarrhea within this community (19).
Infants and young children hospitalized because of an EAd
infection were more likely to have persistent symptoms and to
be admitted later in the course of their illness than those
suffering from the more common rotavirus infection, in which
the onset is acute and associated with dehydration. As previ-
ously observed in the Northern Hemisphere, Ad40 was re-
placed by Ad41 as the dominant serotype, and a new finding
was the annual fluctuation of EAd gastroenteritis during the
12-year study period. Whether increased activity was associ-
ated with genomic or antigenic variation in the circulating
Ad41 strains is unknown but is worthy of further study should
vaccine development be planned in the future.
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